SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001129928-24-000024
Filing Date
2024-04-12
Accepted
2024-04-12 11:03:38
Documents
8
Period of Report
2024-04-12

Document Format Files

Seq Description Document Type Size
1 6-K a2024informationcircularfo.htm 6-K 20137
2 EX-99.1 onc-2024circularxfinal.htm EX-99.1 543890
3 EX-99.2 oncolytics-proxy2024fina.htm EX-99.2 9807
4 image_3.jpg GRAPHIC 74787
5 image_5.jpg GRAPHIC 305260
6 image_7.jpg GRAPHIC 91994
7 oncolytics-proxy2024fina001.jpg GRAPHIC 153883
8 oncolytics-proxy2024fina002.jpg GRAPHIC 207511
  Complete submission text file 0001129928-24-000024.txt   1722744
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38512 | Film No.: 24840407
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)